EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 255 filers reported holding EDITAS MEDICINE INC in Q2 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $119 | -17.9% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $145 | -99.9% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $201,000 | +3.6% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $194,000 | -37.8% | 16,400 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $312,000 | -28.3% | 16,400 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $435,000 | -35.5% | 16,400 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $674,000 | -27.4% | 16,400 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $929,000 | +108.8% | 16,400 | +54.7% | 0.01% | +66.7% |
| Q1 2021 | $445,000 | -32.5% | 10,600 | +12.8% | 0.00% | -25.0% |
| Q4 2020 | $659,000 | +149.6% | 9,400 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $264,000 | -52.5% | 9,400 | -50.0% | 0.00% | 0.0% |
| Q2 2020 | $556,000 | -81.9% | 18,800 | -86.1% | 0.00% | -96.8% |
| Q4 2018 | $3,071,000 | -64.3% | 135,000 | -50.0% | 0.06% | -41.5% |
| Q3 2018 | $8,592,000 | +99.8% | 270,000 | +125.0% | 0.11% | +26.2% |
| Q2 2018 | $4,300,000 | – | 120,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deep Track Capital, LP | 7,101,935 | $55,395,093 | 2.14% |
| Green Alpha Advisors, LLC | 77,188 | $602,066 | 0.46% |
| Woodline Partners LP | 3,259,710 | $25,425,738 | 0.30% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $1,560,000 | 0.22% |
| Spectrum Planning & Advisory Services Inc. | 14,038 | $109,496 | 0.17% |
| PDT Partners, LLC | 156,515 | $1,220,817 | 0.15% |
| CALTON & ASSOCIATES, INC. | 13,420 | $104,676 | 0.15% |
| Corton Capital Inc. | 29,365 | $229,047 | 0.12% |
| CAXTON ASSOCIATES LP | 61,223 | $477,539 | 0.07% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 119,287 | $930,439 | 0.06% |